Gonnelli, A., Cantarella, M., Molinari, A., Villani, G., Lombardi, G., Fabrini, M., . . . Paiar, F. (2017). P09.41 Single agent Bevacizumab in recurrent glioblastoma after a second line chemotherapy with Fotemustine. The Italian Association of Neuro Oncology experience. Neuro Oncol.
Παραπομπή Chicago StyleGonnelli, A., et al. "P09.41 Single Agent Bevacizumab in Recurrent Glioblastoma After a Second Line Chemotherapy With Fotemustine. The Italian Association of Neuro Oncology Experience." Neuro Oncol 2017.
Παραπομπή MLAGonnelli, A., et al. "P09.41 Single Agent Bevacizumab in Recurrent Glioblastoma After a Second Line Chemotherapy With Fotemustine. The Italian Association of Neuro Oncology Experience." Neuro Oncol 2017.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.